$CAH 3 SEC Filings

Filed On	Filing
07 Jan 2026	Form 3: Pitteroff Valerie Christine, CHRO Holds 4,040 shares of Common Shares
11 Mar 2025	Form 3: Ramakrishna Sudhakar, Director Holds 0 shares of Common Shares
11 Mar 2025	Form 3: Musslewhite Robert W, Director Holds 0 shares of Common Shares
01 Mar 2024	Form 3: Azelby Robert, Director No securities owned
16 Feb 2023	Form 3: Alt Aaron E, Chief Financial Officer No securities owned
29 Sep 2022	Form 3: Weitzman Deborah, CEO, Pharmaceutical Segment Holds 27,301 shares of Common Shares
15 Sep 2022	Form 3: Barg Steven, Director No securities owned
15 Sep 2022	Form 3: Mundkur Christine, Director No securities owned
15 Sep 2022	Form 3: Chandrasekaran Sujatha, Director No securities owned
15 Sep 2022	Form 3: Brennan Michelle, Director No securities owned
12 Sep 2022	Form 3: Scherer Mary C., Chief Accounting Officer Holds 18,525 shares of Common Shares
06 Sep 2022	Form 3: Greene Michelle D., Chief Information Officer Holds 14,324 shares of Common Shares
10 Sep 2020	Form 3: English Patricia M, Chief Accounting Officer Holds 9,376 shares of Common Shares
10 Sep 2020	Form 3: Edison Sheri H., Director No securities owned
08 Jul 2020	Form 3: Evans David C, Director No securities owned
01 Jun 2020	Form 3: Hollar Jason M., Chief Financial Officer Holds 20,429 shares of Common Shares
03 Sep 2019	Form 3: Scarborough Dean A, Director No securities owned
03 Sep 2019	Form 3: Weiland John H, Director No securities owned
03 Sep 2019	Form 3: Evans David C, Chief Financial Officer No securities owned
26 Aug 2019	Form 3: Mason Stephen M, CEO, Medical Segment Holds 35,029 shares of Common Shares

Comments